Galexxy Holdings Finalizes its Acquisition Of WellBeing Farms LLC
August 04, 2022 09:00 ET
|
Galexxy Holdings Inc.
Newport Beach, CALIFORNIA, Aug. 04, 2022 (GLOBE NEWSWIRE) -- Galexxy Holdings Inc., (“Galexxy,” “GXXY”) (OTC: GXXY) is pleased to announce that it has finalized the acquisition of WellBeing Farms...
Mydecine Files Full Patent Application Covering MYCO-006 Family of Novel Short-Acting MDMA Analogs
July 19, 2022 07:00 ET
|
Mydecine Innovations Group Inc.
DENVER, July 19, 2022 (GLOBE NEWSWIRE) -- Mydecine Innovations Group Inc. (NEO: MYCO) (OTC: MYCOF) (FSE: 0NFA) (“Mydecine” or the “Company”), a biotechnology company aiming to transform the...
Optimi Health Finalizes Psilocybin Supply Agreement With Bloom Psychedelic Therapy And Research Centre
July 13, 2022 09:00 ET
|
Optimi Health Corp.
VANCOUVER, British Columbia, July 13, 2022 (GLOBE NEWSWIRE) -- Optimi Health Corp. (CSE: OPTI) (OTCQX: OPTHF) (FRA: 8BN) (“Optimi” or the “Company”), a homegrown, Canadian company cultivating and...
Optimi Health Initiates Agreement With SABI Mind For Therapeutic Supplies Of Psilocybin, MDMA
June 28, 2022 09:00 ET
|
Optimi Health Corp.
VANCOUVER, British Columbia, June 28, 2022 (GLOBE NEWSWIRE) -- Optimi Health Corp. (CSE: OPTI) (OTCQX: OPTHF) (FRA: 8BN) (“Optimi” or the “Company”), a homegrown, Canadian company producing natural,...
Optimi Health Requests Approval To Manufacture MDMA, Other Synthetic Psychedelics
June 20, 2022 09:00 ET
|
Optimi Health Corp.
VANCOUVER, British Columbia, June 20, 2022 (GLOBE NEWSWIRE) -- Optimi Health Corp. (CSE: OPTI) (OTCQX: OPTHF) (FRA: 8BN) (“Optimi” or the “Company”), a homegrown, Canadian company producing natural,...
Optimi Health Finalizes Partnership and Psilocybin Supply Agreement With ATMA Journey Centers
June 08, 2022 09:00 ET
|
Optimi Health Corp.
VANCOUVER, British Columbia, June 08, 2022 (GLOBE NEWSWIRE) -- Optimi Health Corp. (CSE: OPTI) (OTCQX: OPTHF) (FRA: 8BN) (“Optimi” or the “Company”), a homegrown, Canadian company producing natural,...
Optimi Health Enters Into Psilocybin Supply Agreement With Filament Health
May 31, 2022 09:00 ET
|
Optimi Health Corp.
VANCOUVER, British Columbia, May 31, 2022 (GLOBE NEWSWIRE) -- Optimi Health Corp. (CSE: OPTI) (OTCQX: OPTHF) (FRA: 8BN) (“Optimi” or the “Company”), a homegrown, Canadian company producing natural,...
Optimi Health Signs Psilocybin Supply Agreement With Halucenex Life Sciences Inc.
May 27, 2022 09:00 ET
|
Optimi Health Corp.
VANCOUVER, British Columbia, May 27, 2022 (GLOBE NEWSWIRE) -- Optimi Health Corp. (CSE: OPTI) (OTCQX: OPTHF) (FRA: 8BN) (“Optimi” or the “Company”), a homegrown, Canadian company producing natural,...
U.K. Member of Parliament Crispin Blunt To Inaugurate Psilocybin Cultivation Facility At Optimi Health Grand Opening
May 19, 2022 09:00 ET
|
Optimi Health Corp.
VANCOUVER, British Columbia, May 19, 2022 (GLOBE NEWSWIRE) -- Optimi Health Corp. (CSE: OPTI) (OTCQX: OPTHF) (FRA: 8BN) (“Optimi” or the “Company”), a homegrown, Canadian company producing natural,...
Optimi Health Acquires Extensive Catalog of Psychedelic and Functional Mushroom Genetics
May 17, 2022 09:00 ET
|
Optimi Health Corp.
VANCOUVER, British Columbia, May 17, 2022 (GLOBE NEWSWIRE) -- Optimi Health Corp. (CSE: OPTI) (OTCQX: OPTHF) (FRA: 8BN) (“Optimi” or the “Company”), a homegrown, Canadian company producing natural,...